DIETARY SUPPLEMENTS AND HERBAL PRODUCTS DURING ANTICANCER TREATMENT: PREVALENCE, INTERACTIONS AND THE PROBLEM OF NON-DISCLOSURE. A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6475Keywords:
Dietary Supplements, Herbal Medicine, Clinical Oncology, Herb–Drug Interactions, Physician–Patient Communication, DisclosureAbstract
Objectives: Dietary supplements and herbal products are widely used by patients undergoing anticancer treatment, and a considerable proportion of this use is never mentioned to their physician. This review summarises current evidence on the prevalence of such use, the pharmacological basis of interactions with anticancer agents, and the factors underlying non-disclosure on the part of both patients and clinicians.
Methods: PubMed/MEDLINE and Google Scholar were searched for publications from January 2011, and July 2026, using combinations of terms relating to dietary supplements, herbal medicine, oncological treatment, herb–drug interactions and physician–patient communication. Priority was given to systematic reviews, meta-analyses and studies conducted in populations receiving anticancer treatment.
Key findings: Reported prevalence varies widely between studies, depending on which products are counted and on the populations examined. Interactions arise principally through effects on drug metabolism and transport. Patients most often cite the absence of any question from the clinician as their reason for not disclosing; clinicians, in turn, describe their own knowledge of these products as insufficient. Training programmes have been developed to address this, but their effectiveness has yet to be established.
Conclusions: Interactions between anticancer agents and dietary supplements or herbal products may be clinically relevant, yet often go unrecognised because their use is not disclosed. Non-disclosure is better understood as a feature of the consultation than as a behaviour of the patient. Two forms of intervention follow: strengthening clinicians' competence, and making enquiry about supplement use routine and free of judgement.
References
Al-Masri, M., Darwish, R., Safi, Y., Mustafa, A., Alzyoud, D., Almasri, M., Kahhaleh, B., & Khader, M. (2025). Herbal and alternative medicine use: A cross sectional study to evaluate the prevalence and predictors of use in cancer patients. Frontiers in Pharmacology, 16, 1535795. https://doi.org/10.3389/fphar.2025.1535795
Ambrosone, C. B., Zirpoli, G. R., Hutson, A. D., McCann, W. E., McCann, S. E., Barlow, W. E., Kelly, K. M., Cannioto, R., Sucheston-Campbell, L. E., Hershman, D. L., Unger, J. M., Moore, H. C. F., Stewart, J. A., Isaacs, C., Hobday, T. J., Salim, M., Hortobagyi, G. N., Gralow, J. R., Budd, G. T., & Albain, K. S. (2020). Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). Journal of Clinical Oncology, 38(8), 804–814. https://doi.org/10.1200/JCO.19.01203
Asiimwe, J. B., Nagendrappa, P. B., Atukunda, E. C., Kamatenesi, M. M., Nambozi, G., Tolo, C. U., Ogwang, P. E., & Sarki, A. M. (2021). Prevalence of the use of herbal medicines among patients with cancer: A systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine, 2021, 1–18. https://doi.org/10.1155/2021/9963038
Baladi, A., El Fadli, M., Tafenzi, H. A., El Bouaouidi, K., Benhima, N., Afani, L., Essâdi, I., & Belbaraka, R. (2024). Prevalence and associated factors of herbal medicine use among breast cancer patients: A cross-sectional study in Morocco. Ecancermedicalscience, 18. https://doi.org/10.3332/ecancer.2024.1786
Berretta, M., Dal Lago, L., Tinazzi, M., Ronchi, A., La Rocca, G., Montella, L., Di Francia, R., Facchini, B. A., Bignucolo, A., & Montopoli, M. (2022). Evaluation of concomitant use of anticancer drugs and herbal products: From interactions to synergic activity. Cancers, 14(21), 5203. https://doi.org/10.3390/cancers14215203
Berretta, M., Pepa, C. D., Tralongo, P., Fulvi, A., Martellotta, F., Lleshi, A., Nasti, G., Fisichella, R., Romano, C., De Divitiis, C., Taibi, R., Fiorica, F., Di Francia, R., Di Mari, A., Del Pup, L., Crispo, A., De Paoli, P., Santorelli, A., Quagliariello, V., … Facchini, G. (2017). Use of complementary and alternative medicine (CAM) in cancer patients: An Italian multicenter survey. Oncotarget, 8(15), 24401–24414. https://doi.org/10.18632/oncotarget.14224
Brokaar, E. J., Van Den Bos, F., Portielje, J. E. A., & Visser, L. E. (2025). The prevalence of clinically relevant herb-drug interactions between herbal products and anti-cancer therapy in older adults with cancer – A cross-sectional study. Exploratory Research in Clinical and Social Pharmacy, 18, 100585. https://doi.org/10.1016/j.rcsop.2025.100585
Buckner, C. A., Lafrenie, R. M., Dénommée, J. A., Caswell, J. M., & Want, D. A. (2018). Complementary and alternative medicine use in patients before and after a cancer diagnosis. Current Oncology, 25(4), 275–281. https://doi.org/10.3747/co.25.3884
Choi, S., Karki Kunwor, S., Im, H., Choi, D., Hwang, J., Ahmed, M., & Han, D. (2024). Traditional and complementary medicine use among cancer patients in Asian countries: A systematic review and meta-analysis. Cancers, 16(18), 3130. https://doi.org/10.3390/cancers16183130
Cowan, A. E., Jun, S., Gahche, J. J., Tooze, J. A., Dwyer, J. T., Eicher-Miller, H. A., Bhadra, A., Guenther, P. M., Potischman, N., Dodd, K. W., & Bailey, R. L. (2018). Dietary supplement use differs by socioeconomic and health-related characteristics among U.S. adults, NHANES 2011–2014. Nutrients, 10(8), 1114. https://doi.org/10.3390/nu10081114
Davis, E. L., Oh, B., Butow, P. N., Mullan, B. A., & Clarke, S. (2012). Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: A systematic review. The Oncologist, 17(11), 1475–1481. https://doi.org/10.1634/theoncologist.2012-0223
Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the Approximation of the Laws of the Member States Relating to Food Supplements (Consolidated Version of 26 November 2025), Official Journal of the European Communities, 51 (2025). https://eur-lex.europa.eu/eli/dir/2002/46/2025-11-26
Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 Amending, as Regards Traditional Herbal Medicinal Products, Directive 2001/83/EC on the Community Code Relating to Medicinal Products for Human Use., Official Journal of the European Union, 85 (2004). http://data.europa.eu/eli/dir/2004/24/oj
Du, M., Luo, H., Blumberg, J. B., Rogers, G., Chen, F., Ruan, M., Shan, Z., Biever, E., & Zhang, F. F. (2020). Dietary supplement use among adult cancer survivors in the United States. The Journal of Nutrition, 150(6), 1499–1508. https://doi.org/10.1093/jn/nxaa040
Dwyer, J., Coates, P., & Smith, M. (2018). Dietary supplements: Regulatory challenges and research resources. Nutrients, 10(1), 41. https://doi.org/10.3390/nu10010041
Foley, H., Steel, A., Cramer, H., Wardle, J., & Adams, J. (2019). Disclosure of complementary medicine use to medical providers: A systematic review and meta-analysis. Scientific Reports, 9(1), 1573. https://doi.org/10.1038/s41598-018-38279-8
Gandhi, A., Master, S., & Bhise, V. (2025). When nature meets oncology: Unraveling herb–drug interactions in cancer therapy. International Journal of Molecular Sciences, 26(21), 10494. https://doi.org/10.3390/ijms262110494
Goey, A. K. L., Meijerman, I., Rosing, H., Marchetti, S., Mergui-Roelvink, M., Keessen, M., Burgers, J. A., Beijnen, J. H., & Schellens, J. H. M. (2014). The effect of St John’s wort on the pharmacokinetics of docetaxel. Clinical Pharmacokinetics, 53(1), 103–110. https://doi.org/10.1007/s40262-013-0102-5
Gras, M., Vallard, A., Brosse, C., Beneton, A., Sotton, S., Guyotat, D., Fournel, P., Daguenet, E., Magné, N., & Morisson, S. (2019). Use of complementary and alternative medicines among cancer patients: A single-center study. Oncology, 97(1), 18–25. https://doi.org/10.1159/000499629
Helmer, S. M., Rogge, A. A., King, R., Canella, C., Pach, D., & Witt, C. M. (2023). Effects of blended learning training for oncology physicians to advise their patients about complementary and integrative therapies: Results from the multicenter cluster-randomized KOKON-KTO trial. BMC Cancer, 23(1), 836. https://doi.org/10.1186/s12885-023-11348-6
Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., & Zwahlen, M. (2012). How many cancer patients use complementary and alternative medicine: A systematic review and metaanalysis. Integrative Cancer Therapies, 11(3), 187–203. https://doi.org/10.1177/1534735411423920
Iłowiecka, K., Maślej, M., Czajka, M., Pawłowski, A., Więckowski, P., Styk, T., Gołkiewicz, M., Kuzdraliński, A., & Koch, W. (2022). Lifestyle, eating habits, and health behaviors among dietary supplement users in three European countries. Frontiers in Public Health, 10, 892233. https://doi.org/10.3389/fpubh.2022.892233
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023). Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging. Archives of Toxicology, 97(10), 2499–2574. https://doi.org/10.1007/s00204-023-03562-9
Kasprzycka, K., Kurzawa, M., Kucharz, M., Godawska, M., Oleksa, M., Stawowy, M., Slupinska-Borowka, K., Sznek, W., Gisterek, I., Boratyn-Nowicka, A., Rucinska, M., Osowiecka, K., & Nawrocki, S. (2022). Complementary and alternative medicine use in hospitalized cancer patients—study from Silesia, Poland. International Journal of Environmental Research and Public Health, 19(3), 1600. https://doi.org/10.3390/ijerph19031600
Keene, M. R., Heslop, I. M., Sabesan, S. S., & Glass, B. D. (2019). Complementary and alternative medicine use in cancer: A systematic review. Complementary Therapies in Clinical Practice, 35, 33–47. https://doi.org/10.1016/j.ctcp.2019.01.004
Kus, F., Can Guven, D., Yildirim, H. C., Akagunduz, B., Karakaya, S., Sutcuoglu, O., Chalabiyev, E., Akyildiz, A., Koksal, B., Sahin, Y. B., Karaca, E., Kavruk, O. A., Zor, N. T., Sirvan, F., Yazici, O., & Yalcin, S. (2024). The use of herbal medicine and dietary supplements in cancer patients receiving immune checkpoint inhibitors: A multicenter cross-sectional study. Integrative Cancer Therapies, 23, 15347354241280273. https://doi.org/10.1177/15347354241280273
Lam, C. S., Koon, H. K., Ma, C. T., Au, K. Y., Zuo, Z., Chung, V. C.-H., & Cheung, Y. T. (2022). Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies. Phytomedicine, 103, 154247. https://doi.org/10.1016/j.phymed.2022.154247
Lee, R. T., Barbo, A., Lopez, G., Melhem-Bertrandt, A., Lin, H., Olopade, O. I., & Curlin, F. A. (2014). National survey of US oncologists’ knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. Journal of Clinical Oncology, 32(36), 4095–4101. https://doi.org/10.1200/JCO.2014.55.8676
Levy, A. G., Scherer, A. M., Zikmund-Fisher, B. J., Larkin, K., Barnes, G. D., & Fagerlin, A. (2018). Prevalence of and factors associated with patient nondisclosure of medically relevant information to clinicians. JAMA Network Open, 1(7), e185293. https://doi.org/10.1001/jamanetworkopen.2018.5293
Limbrunner, J., Doerfler, J., Pietschmann, K., Buentzel, J., Scharpenberg, M., & Huebner, J. (2025). The influence of antioxidant supplementation on adverse effects and tumor interaction during radiotherapy: A systematic review. Clinical and Experimental Medicine, 25(1), 258. https://doi.org/10.1007/s10238-025-01804-x
Luo, Q., & Asher, G. N. (2018). Use of dietary supplements at a comprehensive cancer center. The Journal of Alternative and Complementary Medicine, 24(9–10), 981–987. https://doi.org/10.1089/acm.2018.0183
Marsh, J., Hager, C., Havey, T., Sprague, S., Bhandari, M., & Bryant, D. (2009). Use of alternative medicines by patients with OA that adversely interact with commonly prescribed medications. Clinical Orthopaedics & Related Research, 467(10), 2705–2722. https://doi.org/10.1007/s11999-009-0764-3
Nicolussi, S., Drewe, J., Butterweck, V., & Meyer Zu Schwabedissen, H. E. (2020). Clinical relevance of St. John’s wort drug interactions revisited. British Journal of Pharmacology, 177(6), 1212–1226. https://doi.org/10.1111/bph.14936
Organisation mondiale de la santé (Ed.). (2019). WHO global report on traditional and complementary medicine, 2019. World Health Organization.
Papatesta, E. M., Kanellou, A., Peppa, E., & Trichopoulou, A. (2023). Is dietary (food) supplement intake reported in European national nutrition surveys? Nutrients, 15(24), 5090. https://doi.org/10.3390/nu15245090
Poonthananiwatkul, B., Howard, R. L., Williamson, E. M., & Lim, R. H. M. (2015). Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm. Journal of Ethnopharmacology, 175, 58–66. https://doi.org/10.1016/j.jep.2015.08.052
Powell, C. B., Dibble, S. L., Dall’Era, J. E., & Cohen, I. (2002). Use of herbs in women diagnosed with ovarian cancer. International Journal of Gynecological Cancer, 12(2), 214–217. https://doi.org/10.1136/ijgc-00009577-200203000-00013
Puskulluoglu, M., Uchańska, B., Tomaszewski, K. A., Zygulska, A. L., Zielińska, P., & Grela-Wojewoda, A. (2021). Use of complementary and alternative medicine among Polish cancer patients. Nowotwory. Journal of Oncology, 71(5), 274–281. https://doi.org/10.5603/NJO.a2021.0051
Quandt, S. A., Verhoef, M. J., Arcury, T. A., Lewith, G. T., Steinsbekk, A., Kristoffersen, A. E., Wahner-Roedler, D. L., & Fønnebø, V. (2009). Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). The Journal of Alternative and Complementary Medicine, 15(4), 331–339. https://doi.org/10.1089/acm.2008.0521
Roberts, C. S., Baker, F., Hann, D., Runfola, J., Witt, C., McDonald, J., Livingston, M. L., Ruiterman, J., Ampela, R., Kaw, O. C., & Blanchard, C. (2005). Patient-physician communication regarding use of complementary therapies during cancer treatment. Journal of Psychosocial Oncology, 23(4), 35–60. https://doi.org/10.1300/J077v23n04_03
Rogge, A. A., Helmer, S. M., Icke, K., & Witt, C. M. (2024). Effects of training oncology physicians advising patients on complementary and integrative therapies on patient‐reported outcomes: 2‐year follow‐up of the multi‐center, cluster‐randomized KOKON‐KTO study. Cancer Medicine, 13(14), e70008. https://doi.org/10.1002/cam4.70008
Ryan, J. L., Heckler, C. E., Roscoe, J. A., Dakhil, S. R., Kirshner, J., Flynn, P. J., Hickok, J. T., & Morrow, G. R. (2012). Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: A URCC CCOP study of 576 patients. Supportive Care in Cancer, 20(7), 1479–1489. https://doi.org/10.1007/s00520-011-1236-3
Schofield, P., Diggens, J., Charleson, C., Marigliani, R., & Jefford, M. (2010). Effectively discussing complementary and alternative medicine in a conventional oncology setting: Communication recommendations for clinicians. Patient Education and Counseling, 79(2), 143–151. https://doi.org/10.1016/j.pec.2009.07.038
Tank, M., Franz, K., Cereda, E., & Norman, K. (2021). Dietary supplement use in ambulatory cancer patients: A survey on prevalence, motivation and attitudes. Journal of Cancer Research and Clinical Oncology, 147(7), 1917–1925. https://doi.org/10.1007/s00432-021-03594-7
Witt, C. M., Helmer, S. M., Schofield, P., Wastell, M., Canella, C., Thomae, A. V., & Rogge, A. A. (2020). Training oncology physicians to advise their patients on complementary and integrative medicine: An implementation study for a manual‐guided consultation. Cancer, 126(13), 3031–3041. https://doi.org/10.1002/cncr.32823
Woldeselassie, M., & Tamene, A. (2024). Therapeutic controversies over use of antioxidant supplements during cancer treatment: A scoping review. Frontiers in Nutrition, 11, 1480780. https://doi.org/10.3389/fnut.2024.1480780
Wolf, C. P. J. G., Rachow, T., Ernst, T., Hochhaus, A., Zomorodbakhsch, B., Foller, S., Rengsberger, M., Hartmann, M., & Huebner, J. (2022). Complementary and alternative medicine (CAM) supplements in cancer outpatients: Analyses of usage and of interaction risks with cancer treatment. Journal of Cancer Research and Clinical Oncology, 148(5), 1123–1135. https://doi.org/10.1007/s00432-021-03675-7
Yang, G., Lee, R., Zhang, H., Gu, W., Yang, P., & Ling, C. (2017). National survey of China’s oncologists’ knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine. Oncotarget, 8(8), 13440–13449. https://doi.org/10.18632/oncotarget.14560
Zhou, H., Zhang, M., Cao, H., Du, X., Zhang, X., Wang, J., & Bi, X. (2023). Research progress on the synergistic anti-tumor effect of natural anti-tumor components of Chinese herbal medicine combined with chemotherapy drugs. Pharmaceuticals, 16(12), 1734. https://doi.org/10.3390/ph16121734
Ziemann, J., Lendeckel, A., Müller, S., Horneber, M., & Ritter, C. A. (2019). Herb-drug interactions: A novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment. European Journal of Clinical Pharmacology, 75(9), 1237–1248. https://doi.org/10.1007/s00228-019-02700-6
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Agata Kotlowska, Julia Lenkiewicz, Wiktoria Napiórkowska, Marcin Trzciński, Oliwia Lenkiewicz, Aleksandra Izabela Masłowska, Zuzanna Chmielewska, Anna Gwóźdź-Broczkowska, Gabriela Luba, Dominika Galińska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
